Validation studies using 109 CRC samples, 317 healthy control samples, and 87 samples from patients with benign large bowel diseases revealed that the diagnostic accuracy of PSME3 was similar to that of CEA, and that NNMT was better than CEA at detecting CRC. The gene discussed is CEACAM5; the disease is colorectal carcinoma.